GSMA
23.9.2020 13:27:09 CEST | Business Wire | Press release
GSMA today announced a rescheduling of its world-class MWC series for 2021. MWC21 Shanghai will now take place from 23 – 25 February 2021, and MWC21 Barcelona will now take place between 28 June – 1 July 2021.
Moving MWC21 Barcelona, initially scheduled for the first week of March 2021, allows the GSMA to contend with external circumstances related to Covid-19.
The GSMA is committed and investing so that MWC21 Barcelona can go ahead safely and offer the unique, unmissable experience that has made it the world’s most important mobile ecosystem convening platform. MWC21 Barcelona will also have virtual elements to complement the overwhelming demand to convene physically.
Mats Granryd, Director General, GSMA said: “With a continuously changing global outlook and following consultation with our board and membership and our top exhibitors, we have taken the careful decision to reschedule MWC21 Shanghai in February, and MWC21 Barcelona in June. The health and safety of our exhibitors, attendees, staff and the people of Barcelona are of paramount importance.”
John Hoffman, CEO GSMA Ltd., said: “We have been overwhelmed by the support of all our partners and clients who remain dedicated to ensuring MWC21 Barcelona is a success. MWC is more than just an event. It’s an experience that brings the whole industry together and provides a platform to unlock the power of connectivity so that people, industry and society thrive.”
The rescheduling respects the global circumstance surrounding Covid-19. It recognises that both events are catalysts in the mobile ecosystem; they are platforms for launching new products and innovations, bringing together decision and deal makers.
The GSMA continues to work closely with the Host City Parties, and the decision to change the date of MWC21 Barcelona follows a period of planning and consultation with all major stakeholders. The date changes also ensure that 2021 reverts to a full annual cycle of MWC events between Shanghai, Barcelona and LA. Both the Host City Parties and the GSMA board support the decision of the GSMA.
Pau Relat, President of Governing board of Fira de Barcelona, said: “We fully support the GSMA’s decision to reschedule the dates for MWC Barcelona and are deeply committed to making the best possible 2021 edition with an extraordinary participation of companies and visitors. The long-standing partnership between the MWC, Fira and the city of Barcelona has been a very successful one for everyone, and I’m sure it will continue to be so in the future.”
Over the balance of 2020, the GSMA remains excited about its virtual series, Thrive, with remaining events in Africa, North America, Asia Pacific, Eurasia and Latin America. For more information, please click here, https://www.gsmathrive.com/ .
- ENDS -
Notes to Editors
Host City Parties include: Barcelona City Council, Generalitat de Catalunya, the Ministry of Industry, Energy and Tourism, Fira de Barcelona, Tourism de Barcelona
About GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with almost 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005487/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®8.7.2026 16:05:00 CEST | Press release
New data highlight multi-center 5-year durability, 10-year survival, and the largest single-center experience across both HFrEF and HFpEF patients with functional mitral regurgitation Cardiac Dimensions, a leader in transcatheter therapies for heart failure, today announced the publication of three major manuscripts that together form the most comprehensive evidence base ever assembled for transcatheter indirect mitral annuloplasty. These publications span a five-year multi-center commercial registry, the largest single-center experience across both preserved and reduced ejection fraction, and long-term survival results through ten years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707656796/en/ Carillon Mitral Contour System® The Carillon Mitral Contour System is the only commercially available indirect mitral annuloplasty device, designed to treat a broad and expanding population of patients living with functional mi
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom